MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Ataxia: Clinical features"

  • 2024 International Congress

    A Novel SLC9A1 Mutation Associated with Cerebellar Ataxia and Sensorineural Hearing Loss

    S. Dharmadhikari, Y. Kianirad (Chicago, USA)

    Objective: To report a novel genetic mutation in the SLC9A1 gene presenting with childhood onset ataxia and sensorineural hearing loss. Background: Lichtenstein-Knorr syndrome is a…
  • 2024 International Congress

    Ataxia Telangiectasia Diagnosis in Lower-Middle-Income Countries: A Case Report

    H. Ngo Thi, T. Nguyen Anh (Hanoi, Viet Nam)

    Objective: to describe clinical features and diagnostic tests in a patient with Ataxia Telangiectasia (AT) in Vietnam. Background: AT is a rare hereditary syndrome, the…
  • 2024 International Congress

    Phenotypic Variability of PRNP and Related Movement Disorders

    M. Tuesta Bernaola, J. Ganguly, M. Jog (London, Canada)

    Objective: Delineation of clinical and genetic features of PRNP-related movement disorders in two families. Background: Genetic prion disease can have a variable and overlapping phenotypic presentation…
  • 2024 International Congress

    Syllable-based speech characteristics as potential biomarker for differential diagnosis of Parkinson’s disease, multiple system atrophy, and cerebellar ataxia

    B. Jin, H. Kim, K. Woo, J. Shin (Seoul, Republic of Korea)

    Objective: To analyze syllable-based speech characteristics in patients with Parkinson’s disease (PD), multiple system atrophy (MSA), and cerebellar ataxia (CA) to determine if there is…
  • 2024 International Congress

    Opsoclonus after Covid-19 infection

    F. Sakeff, A. Vilar (São Paulo, Brazil)

    Objective: Describe the first Brazilian case of opsoclonus due to COVID-19 infection Background: Opsoclonus-myoclonus is a rare movement disorder associated with a variety of conditions,…
  • 2024 International Congress

    Spastic Ataxia and Motorneuron disease as possible manifestations of ATP13A2 (PARK 9) variants

    G. Dalla Zanna, A. Funcis, S. Rossi, F. Santorelli, M. Sabatelli, G. Silvestri (Rome, Italy)

    Objective: To describe 5 late-onset sporadic cases carrying either biallelic or monoallelic variants in ATP13A2, showing either spastic ataxia(Spatax) or primary lateral sclerosis (PLS) as…
  • 2024 International Congress

    The Clinical Implication of Dysphagia in Patients with Multiple System Atrophy

    MG. Choi, SY. Jo, JH. Lee, SJ. Chung (Seoul, Republic of Korea)

    Objective: This study aimed to explore the correlation between dysphagia and key clinical features in Multiple System Atrophy (MSA) patients, along with investigating the link…
  • 2024 International Congress

    Oculomotor Biomarkers for Cerebellar Ataxia and Severity in Smooth Pursuit

    P. Ponger, G. Gurevich, R. Alcalay, Y. Bonneh, S. Shani (Tel Aviv, Israel)

    Objective: Our research utilizes the technique of brief linear smooth pursuit of a moving target, to derive various parameters. These parameters are then analyzed to…
  • 2024 International Congress

    Satisfaction with telemedicine of patients with movement disorders on the Pacific coast of Colombia.

    L. Ortega-Bolaños, D. Bolaños-Ortega, K. Ortega-Dorado, K. Martinez-Ortega (Cali, Colombia)

    Objective: Determine the level of satisfaction with the telemedicine consultation of patients with movement disorders on the Pacific coast of Valle del Cauca, in Colombia,…
  • 2024 International Congress

    Prevalence of Movement Disorders in Epilepsy Patients Taking Antiepileptics Drugs in a Tertiary Care Teaching Hospital in Nepal.

    N. Guragain, P. Gyawanli, A. Mudvari, P. Prasad, R. Ghimire, B. Gajurel, R. Ojha (Kathmandu, Nepal)

    Objective: To assess the prevalence of movement disorders in epilepsy patients taking antiepileptics drugs. Background: A prospective longitudinal observational study was conducted for one year…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 31
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley